Categories
Change Password!
Reset Password!
Using hormonal contraceptives may lower
fibromyalgia risk in females having dysmenorrhea.
A study depicted that dysmenorrhea may be a vital risk factor of developing fibromyalgia. Compared to females without dysmenorrhea, females with dysmenorrhea have a considerably greater risk of fibromyalgia. Treating dysmenorrhea with hormonal contraceptives minimized the risk of fibromyalgia suggesting that personalized medicine for mitigating dysmenorrhea may be vital to minimize fibromyalgia risk.
A cohort study was carried out to analyze whether females with dysmenorrhea have an elevated risk of fibromyalgia and whether treating dysmenorrhea alleviates fibromyalgia risk. The Longitudinal Health Insurance Database 2000 from the Taiwan National Health Research Institutes Database was used.
Based
on age, sex, and the year of trial entrance by frequency matching, the
dysmenorrhea group (n=38,243) was matched with a non-dysmenorrhea group
(n=38,243) at a 1:1 ratio. Using the multivariable cox proportional hazard
regression models, the risk of fibromyalgia was determined. The potential
confounding variables such as age, medication use, and comorbidities were
effectively controlled. Fibromyalgia was the primary endpoint of the study.
The
overall prevalence of fibromyalgia and the incidence rate of fibromyalgia was
found to be greater in the dysmenorrhea arm compared to the comparison cohort,
as shown in the following table:
The Kaplan–Meier analysis illustrated that the dysmenorrhea group had a greater cumulative incidence of fibromyalgia than the comparison group at the end of the follow-up period, as shown in the following table:
Thus, hormonal contraceptives appear to be a promising
approach to lower fibromyalgia risk in females with dysmenorrhea.
Journal of Personalized Medicine
Hormonal Contraceptive Treatment May Reduce the Risk of Fibromyalgia in Women with Dysmenorrhea: A Cohort Study
Cheng-Hao Tu et al.
Comments (1)